Commentaries: Art. 140i

The certificate lapses where:
1. the owner surrenders it by a written declaration to the IPI;
2. the annual fees have not been paid in due time;
c.¹all authorisations of medicinal products containing the product are recalled (Art. 16a TPA²).
If all authorisations are suspended, the certificate is also suspended. Suspension does not interrupt the term of the certificate.³
The Swiss Agency for Therapeutic Products shall notify the IPI of any withdrawal or suspension of the authorisations.⁴

Amended by Annex No 2 of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575;BBl 2013 1). ↩
SR 812.21 ↩
Amended by Annex No 2 of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575;BBl 2013 1). ↩
Amended by Annex No 2 of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575;BBl 2013 1). ↩

Art. 140i